Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death

Journal of Biological Chemistry

Volumn 287, Issue 42, 2012, Pages 35444-35453

  Bardai, Farah H ^a   Price, Valerie ^a   Zaayman, Marcus ^a   Wang, Lulu ^a   D'Mello, Santosh R ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; ENZYMES; NEURODEGENERATIVE DISEASES;

CEREBELLAR GRANULE NEURONS; DEACETYLASE ACTIVITY; ECTOPIC EXPRESSIONS; GLYCOGEN SYNTHASE KINASE; HISTONE DEACETYLASES; HUNTINGTON DISEASE; MOLECULAR SWITCHES; NEUROTOXIC EFFECTS;

NEURONS;

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE RELATED PROTEIN; PROTEIN P25; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN CORTEX; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; TAUOPATHY;

EID: 84867431257     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.394544     Document Type: Article

References (37)

1. Yang, X. J., and Seto, E. (2008) The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat. Rev. Mol. Cell Biol. 9, 206-218
2. Haberland, M., Montgomery, R. L., and Olson, E. N. (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42
3. D'Mello, S. R. (2009) Histone deacetylases as targets for the treatment of human neurodegenerative diseases. Drug News Perspect. 22, 513-524
4. Kazantsev, A. G., and Thompson, L. M. (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat. Rev. Drug Discov. 7, 854-868
5. Sleiman, S. F., Basso, M., Mahishi, L., Kozikowski, A. P., Donohoe, M. E., Langley, B., and Ratan, R. R. (2009) Putting the "HAT" back on survival signaling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions. Expert Opin. Investig. Drugs 18, 573-584
6. Majdzadeh, N., Wang, L., Morrison, B. E., Bassel-Duby, R., Olson, E. N., and D'Mello, S. R. (2008) HDAC4 inhibits cell cycle progression and protects neurons from cell death. Dev. Neurobiol. 68, 1076-1092 (Pubitemid 351904928)
7. Morrison, B. E., Majdzadeh, N., Zhang, X., Lyles, A., Bassel-Duby, R., Olson, E. N., and D'Mello, S. R. (2006) Neuroprotection by histone deacetylase-related protein. Mol. Cell Biol. 26, 3550-3564
8. Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., Schwartz, S. L., DiProspero, N. A., Knight, M. A., Schuldiner, O., Padmanabhan, R., Hild, M., Berry, D. L., Garza, D., Hubbert, C. C., Yao, T. P., Baehrecke, E. H., and Taylor, J. P. (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859-863 (Pubitemid 46920134)
9. Pfister, J. A., Ma, C., Morrison, B. E., and D'Mello, S. R. (2008) Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS ONE 3, e4090
10. Kim, D., Frank, C. L., Dobbin, M. M., Tsunemoto, R. K., Tu, W., Peng, P. L., Guan, J. S., Lee, B. H., Moy, L. Y., Giusti, P., Broodie, N., Mazitschek, R., Delalle, I., Haggarty, S. J., Neve, R. L., Lu, Y., and Tsai, L. H. (2008) Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60, 803-817
11. Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., Puigserver, P., Sinclair, D. A., and Tsai, L. H. (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer disease and amyotrophic lateral sclerosis. EMBO J. 26, 3169-3179 (Pubitemid 47057498)
12. Qin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., Zhao, W., Thiyagarajan, M., MacGrogan, D., Rodgers, J. T., Puigserver, P., Sadoshima, J., Deng, H., Pedrini, S., Gandy, S., Sauve, A. A., and Pasinetti, G. M. (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281, 21745-21754 (Pubitemid 44181878)
13. Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L. F., Kwon, H., Yi, S., Mucke, L., and Gan, L. (2005) SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling. J. Biol. Chem. 280, 40364-40374 (Pubitemid 41779174)
14. Bardai, F. H., and D'Mello, S. R. (2011) Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3β. J. Neurosci. 31, 1746-1751
15. Jeong, H., Then, F., Melia, T. J., Jr., Mazzulli, J. R., Cui, L., Savas, J. N., Voisine, C., Paganetti, P., Tanese, N., Hart, A. C., Yamamoto, A., and Krainc, D. (2009) Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137, 60-72
16. Kim, J. Y., Shen, S., Dietz, K., He, Y., Howell, O., Reynolds, R., and Casaccia, P. (2010) HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat. Neurosci. 13, 180-189
17. D'Mello, S. R., Galli, C., Ciotti, T., and Calissano, P. (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. U.S.A. 90, 10989-10993 (Pubitemid 23354354)
18. Wang, L., Ankati, H., Akubathini, S. K., Balderamos, M., Storey, C. A., Patel, A. V., Price, V., Kretzschmar, D., Biehl, E. R., and D'Mello, S. R. (2010) Identification of novel 1,4-benzoxazine compounds that are protective in tissue culture and in vivo models of neurodegeneration. J. Neurosci. Res. 88, 1970-1984
19. Chen, H. M., Wang, L., and D'Mello, S. R. (2008) A chemical compound commonly used to inhibit PKR, {8-(imidazol-4-ylmethylene)-6H-azolidino[5,4-g] benzothiazol-7-one}, protects neurons by inhibiting cyclin-dependent kinase. Eur. J. Neurosci. 28, 2003-2016
20. Ghosh, S., and Feany, M. B. (2004) Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases. Hum. Mol. Genet. 13, 2011-2018 (Pubitemid 39377825)
21. Ma, C., and D'Mello, S. R. (2011) Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism. J. Biol. Chem. 286, 4819-4828
22. Montgomery, R. L., Potthoff, M. J., Haberland, M., Qi, X., Matsuzaki, S., Humphries, K. M., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2008) Maintenance of cardiac energy metabolism by histone deacetylase-3 in mice. J. Clin. Invest. 118, 3588-3597
23. Cruz, J. C., Tseng, H. C., Goldman, J. A., Shih, H., and Tsai, L. H. (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483 (Pubitemid 37494698)
24. Fischer, A., Sananbenesi, F., Pang, P. T., Lu, B., and Tsai, L. H. (2005) Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48, 825-838 (Pubitemid 41759432)
25. Li, J. Y., Popovic, N., and Brundin, P. (2005) The use of the R6 transgenic mouse models of Huntington disease in attempts to develop novel therapeutic strategies. NeuroRx 2, 447-464 (Pubitemid 41444878)
26. D'Mello, S. R., Borodezt, K., and Soltoff, S. P. (1997) Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling. J. Neurosci. 17, 1548-1560 (Pubitemid 27089801)
27. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661-665 (Pubitemid 27061332)
28. Hernández, F., Nido, J. D., Avila, J., and Villanueva, N. (2009) GSK3 inhibitors and disease. Mini Rev. Med. Chem. 9, 1024-1029
29. Bhat, R. V., Budd Haeberlein, S. L., and Avila, J. (2004) Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem. 89, 1313-1317 (Pubitemid 38802652)
30. Shaw, M., Cohen, P., and Alessi, D. R. (1997) Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett. 416, 307-311 (Pubitemid 27475387)
31. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378, 785-789 (Pubitemid 26004411)
32. Borsello, T., and Forloni, G. (2007) JNK signaling: a possible target to prevent neurodegeneration. Curr. Pharm. Des. 13, 1875-1886 (Pubitemid 47010160)
33. Greene, L. A., Liu, D. X., Troy, C. M., and Biswas, S. C. (2007) Cell cycle molecules define a pathway required for neuron death in development and disease. Biochim. Biophys. Acta 1772, 392-401 (Pubitemid 46400389)
34. Grégoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E., and Yang, X. J. (2007) Histone deacetylase-3 interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell Biol. 27, 1280-1295 (Pubitemid 46239812)
35. Tou, L., Liu, Q., and Shivdasani, R. A. (2004) Regulation of mammalian epithelial differentiation and intestine development by Class I histone deacetylases. Mol. Cell Biol. 24, 3132-3139 (Pubitemid 38452059)
36. Morrison, B. E., Majdzadeh, N., and D'Mello, S. R. (2007) Histone deacetylases: focus on the nervous system. Cell. Mol. Life Sci. 64, 2258-2269 (Pubitemid 47347953)
37. Jia, H., Pallos, J., Jacques, V., Lau, A., Tang, B., Cooper, A., Syed, A., Purcell, J., Chen, Y., Sharma, S., Sangrey, G. R., Darnell, S. B., Plasterer, H., Sadri-Vakili, G., Gottesfeld, J. M., Thompson, L. M., Rusche, J. R., Marsh, J. L., and Thomas, E. A. (2012) Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington disease. Neurobiol. Dis. 46, 351-361